​

Telomir Pharmaceuticals (TELO) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChart

Telomir Pharmaceuticals Revenue Highlights

00

Telomir Pharmaceuticals Revenue by Period

Telomir Pharmaceuticals Revenue by Year

DateRevenueChange
2024-12-31-100.00%
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31--

Telomir Pharmaceuticals generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Telomir Pharmaceuticals Revenue by Quarter

DateRevenueChange
2025-09-30-100.00%
2025-06-30-100.00%
2025-03-31--100.00%
2024-12-31$18.79M100.00%
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31-100.00%
2023-12-31-100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31--

Telomir Pharmaceuticals generated - in revenue during Q3 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Telomir Pharmaceuticals Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
KPTIKaryopharm Therapeutics$145.24M$44.04M
EQEquillium$41.09M-
BRNSBarinthus Biotherapeutics$14.97M-
IPSCCentury Therapeutics$6.59M-
INMBINmune Bio$14.00K-
COEPCoeptis Therapeutics-$62.87K
MDCXMedicus Pharma--
GNTAGenenta Science S.p.A.--
TELOTelomir Pharmaceuticals--
SKYESkye Bioscience--

TELO Revenue FAQ

What is Telomir Pharmaceuticals’s yearly revenue?

Telomir Pharmaceuticals's yearly revenue for 2024 was $0, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. TELO's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021.

What is Telomir Pharmaceuticals’s quarterly revenue?

Telomir Pharmaceuticals's quarterly revenue for Q3 2025 was $0, a 100.00% increase from the previous quarter (Q2 2025), and a 0% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $0, a 100.00% increase from the previous quarter (Q1 2025), and a 0% increase year-over-year (Q2 2024). TELO's quarterly revenue for Q1 2025 was $0, a -100.00% decrease from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024).

What is Telomir Pharmaceuticals’s revenue growth rate?

Telomir Pharmaceuticals's revenue growth rate for the last 3 years (2022-2024) was 0%